p53 mutations affect cancer cell metabolism
Nature Cell Biology
February 21, 2011
The loss of the tumour suppressor protein p53 might underlie cancer cells' ability to undergo a metabolic switch that supports rapid proliferation in the face of limited availability of nutrients. This finding, reported online this week in Nature Cell Biology, reinforces the importance of p53 loss in the development of cancer.
p53 is known to modulate cancer cell metabolism by regulating gene transcription within the nucleus. Xiaolu Yang and colleagues recognized that cells lacking functional p53 consumed large quantities of glucose through the ox-PPP pathway, which supports the biosynthesis of new cellular building blocks from glucose and is critical for cancer cell proliferation.
They found that p53 interacts with a key enzyme in the ox-PPP pathway outside of the nucleus. The authors conclude that p53 normally inhibits this enzyme to block the ox-PPP pathway, but that loss of p53 removes this block and activates the pathway. In an accompanying News & Views article, Eyal Gottlieb notes that this "effect of p53…is intriguing as it proposes a catalytic (enzymatic) role for p53 in the cytosol."
doi: 10.1038/ncb2172
Research highlights
-
Jun 29
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports